FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040660384> ?p ?o ?g. }

• W3040660384 abstract "Abstract Background Numerous studies show that the pretreatment neutrophil-to-lymphocyte ratio (NLR) is associated with the prognosis of patients with RCC. However, their findings are inconsistent, urging us to explore the prognostic value of NLR in RCC patients. Methods This study was pre-registered in PROSPERO (CRD42020167131). Two reviewers independently performed a systematical search of PubMed, Web of Science, EMBASE, and Cochrane Library databases for prospective or retrospective cohort studies investigating the prognostic value of pretreatment NLR. Hazard ratios with 95% confidence intervals for overall survival (OS), disease-free survival (DFS), progression-free survival (PFS), cancer-specific survival (CSS), and other useful clinicopathological features were extracted and analyzed with fixed or random-effect models by using Review Manager 5.3 and Stata 12.0 software. Heterogeneity was estimated on the basis of Cochran’s Q test and I 2 value. Sensitivity analyses and subgroup analyses were also performed to explore the potential sources of heterogeneity. Publication bias was assessed with funnel plots and precisely assessed by Egger’s tests. The quality of the evidence was evaluated in accordance with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Results Overall, 6461 RCC patients from 24 retrospective studies and 1 prospective study were included. In overall population, elevated pretreatment NLR was associated with poorer OS (pooled HR = 1.90, 95% CI = 1.56–2.30, p < 0.001; I 2 = 87%), DFS/PFS (pooled HR = 2.09, 95% CI: 1.49–2.94, p < 0.001; I 2 = 99%), and CSS (pooled HR = 2.31, 95% CI: 1.61–3.33, p < 0.001; I 2 = 14%). Furthermore, this negative association was further confirmed in patients with nonmetastatic and metastatic RCC patients, respectively. We also investigated the predictive role of NLR in metastatic RCC patients treated with immune checkpoint inhibitors (ICIs). The results indicated that the level of NLR was significantly associated with OS (pooled HR = 3.92, 95% CI: 2.00–7.69, p < 0.001; I 2 = 0%) and PFS (pooled HR = 2.20, 95% CI: 95% CI: 1.61–3.01, p < 0.001; I 2 = 20%). Conclusions This study demonstrated that elevated pretreatment NLR was significantly associated with poor prognosis of RCC patients. NLR could be helpful as a potential prognostic biomarker to guide clinical decision-making and select individualized treatment strategies for RCC patients." @default.
• W3040660384 created "2020-07-10" @default.
• W3040660384 creator A5044216882 @default.
• W3040660384 creator A5049787568 @default.
• W3040660384 creator A5054373658 @default.
• W3040660384 creator A5068290128 @default.
• W3040660384 creator A5077437390 @default.
• W3040660384 creator A5086058158 @default.
• W3040660384 date "2020-07-06" @default.
• W3040660384 modified "2023-10-10" @default.
• W3040660384 title "Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis" @default.
• W3040660384 cites W1971949115 @default.
• W3040660384 cites W1982906652 @default.
• W3040660384 cites W1986683494 @default.
• W3040660384 cites W1993013170 @default.
• W3040660384 cites W2001853141 @default.
• W3040660384 cites W2014229457 @default.
• W3040660384 cites W2015143684 @default.
• W3040660384 cites W2030711913 @default.
• W3040660384 cites W2033275491 @default.
• W3040660384 cites W2051820020 @default.
• W3040660384 cites W2058615058 @default.
• W3040660384 cites W2075642745 @default.
• W3040660384 cites W2088095316 @default.
• W3040660384 cites W2091553144 @default.
• W3040660384 cites W2104675861 @default.
• W3040660384 cites W2106637705 @default.
• W3040660384 cites W2107328434 @default.
• W3040660384 cites W2111091624 @default.
• W3040660384 cites W2116475791 @default.
• W3040660384 cites W2116554142 @default.
• W3040660384 cites W2117692326 @default.
• W3040660384 cites W2118278569 @default.
• W3040660384 cites W2141269240 @default.
• W3040660384 cites W2168299243 @default.
• W3040660384 cites W2284518822 @default.
• W3040660384 cites W2555843275 @default.
• W3040660384 cites W2558515944 @default.
• W3040660384 cites W2589234404 @default.
• W3040660384 cites W2592775962 @default.
• W3040660384 cites W2598236996 @default.
• W3040660384 cites W2765763462 @default.
• W3040660384 cites W2791302028 @default.
• W3040660384 cites W2883708222 @default.
• W3040660384 cites W2892325025 @default.
• W3040660384 cites W2897038355 @default.
• W3040660384 cites W2899905787 @default.
• W3040660384 cites W2903977846 @default.
• W3040660384 cites W2907809180 @default.
• W3040660384 cites W2908696407 @default.
• W3040660384 cites W2911188335 @default.
• W3040660384 cites W2924538267 @default.
• W3040660384 cites W2926334737 @default.
• W3040660384 cites W2930148820 @default.
• W3040660384 cites W2942780272 @default.
• W3040660384 cites W2943066244 @default.
• W3040660384 cites W2948132055 @default.
• W3040660384 cites W2964818688 @default.
• W3040660384 cites W2965390103 @default.
• W3040660384 cites W2966627095 @default.
• W3040660384 cites W2972923657 @default.
• W3040660384 cites W2972984480 @default.
• W3040660384 cites W2981451658 @default.
• W3040660384 cites W2981524284 @default.
• W3040660384 cites W2990579199 @default.
• W3040660384 cites W2998118691 @default.
• W3040660384 doi "https://doi.org/10.1186/s12894-020-00665-8" @default.
• W3040660384 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7339475" @default.
• W3040660384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32631294" @default.
• W3040660384 hasPublicationYear "2020" @default.
• W3040660384 type Work @default.
• W3040660384 sameAs 3040660384 @default.
• W3040660384 citedByCount "30" @default.
• W3040660384 countsByYear W30406603842020 @default.
• W3040660384 countsByYear W30406603842021 @default.
• W3040660384 countsByYear W30406603842022 @default.
• W3040660384 countsByYear W30406603842023 @default.
• W3040660384 crossrefType "journal-article" @default.
• W3040660384 hasAuthorship W3040660384A5044216882 @default.
• W3040660384 hasAuthorship W3040660384A5049787568 @default.
• W3040660384 hasAuthorship W3040660384A5054373658 @default.
• W3040660384 hasAuthorship W3040660384A5068290128 @default.
• W3040660384 hasAuthorship W3040660384A5077437390 @default.
• W3040660384 hasAuthorship W3040660384A5086058158 @default.
• W3040660384 hasBestOaLocation W30406603841 @default.
• W3040660384 hasConcept C126322002 @default.
• W3040660384 hasConcept C143998085 @default.
• W3040660384 hasConcept C167135981 @default.
• W3040660384 hasConcept C188816634 @default.
• W3040660384 hasConcept C207103383 @default.
• W3040660384 hasConcept C2776478404 @default.
• W3040660384 hasConcept C2777472916 @default.
• W3040660384 hasConcept C2777761686 @default.
• W3040660384 hasConcept C2778963024 @default.
• W3040660384 hasConcept C2780439572 @default.
• W3040660384 hasConcept C2908647359 @default.
• W3040660384 hasConcept C44249647 @default.
• W3040660384 hasConcept C71924100 @default.
• W3040660384 hasConcept C82605166 @default.
• W3040660384 hasConcept C95190672 @default.

• next